VitaNova Life Sciences (VNOV) Short term Debt (2017 - 2018)
VitaNova Life Sciences' (VNOV) quarterly Short term Debt came in at $5600.0 in Q1 2018, little changed on a QoQ basis from $5600.0 in Q2 2017.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Short term Debt (2017 - 2018) Analysis & Trends
VitaNova Life Sciences has disclosed Short term Debt across 2 years of filings, most recently posting $5600.0 for Q1 2018.
- Short term Debt for Q1 2018 came in at $5600.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2018 was $5600.0 (changed N/A YoY), and the FY2018 annual result was $5600.0, changed N/A from the prior year.
- Short term Debt for Q1 2018 stood at $5600.0, roughly flat from $5600.0 in the prior quarter.
- Across five years, Short term Debt topped out at $5600.0 in Q2 2017 and bottomed at $5600.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 |